Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Muscle Nerve ; 53(4): 598-607, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26202157

ABSTRACT

INTRODUCTION: Magnetic stimulation (MS) has the ability to induce muscle twitch and has long been proposed as a therapeutic modality for skeletal muscle diseases. However, the molecular mechanisms underlying its means of action have not been defined. METHODS: Muscle regeneration after trauma was studied in a standard muscle injury mouse model. The influence of MS on the formation of motor units, posttrauma muscle/nerve regeneration, and vascularization was investigated. RESULTS: We found that MS does not cause systemic or muscle damage but improves muscle regeneration by significantly minimizing the presence of inflammatory infiltrate and formation of scars after trauma. It avoids posttrauma muscle atrophy, induces muscle hypertrophy, and increases the metabolism and turnover of muscle. It triples the expression of muscle markers and significantly improves muscle functional recovery after trauma. CONCLUSIONS: Our results indicate that MS supports muscle and nerve regeneration by activating muscle-nerve cross-talk and inducing the maturation of neuromuscular junctions.


Subject(s)
Magnetic Field Therapy/methods , Muscle, Skeletal/injuries , Muscle, Skeletal/physiology , Muscular Atrophy/physiopathology , Muscular Atrophy/therapy , Nerve Regeneration/physiology , Animals , Female , Mice , Mice, Inbred C57BL , Muscle Contraction/physiology , Neuromuscular Junction/physiology , Organ Culture Techniques
2.
Nat Commun ; 5: 3569, 2014 Apr 01.
Article in English | MEDLINE | ID: mdl-24686533

ABSTRACT

The neuromuscular junction (NMJ) exhibits high morphological and functional plasticity. In the mature muscle, the relative levels of physical activity are the major determinants of NMJ function. Classically, motor neuron-mediated activation patterns of skeletal muscle have been thought of as the major drivers of NMJ plasticity and the ensuing fibre-type determination in muscle. Here we use muscle-specific transgenic animals for the peroxisome proliferator-activated receptor γ co-activator 1α (PGC-1α) as a genetic model for trained mice to elucidate the contribution of skeletal muscle to activity-induced adaptation of the NMJ. We find that muscle-specific expression of PGC-1α promotes a remodelling of the NMJ, even in the absence of increased physical activity. Importantly, these plastic changes are not restricted to post-synaptic structures, but extended to modulation of presynaptic cell morphology and function. Therefore, our data indicate that skeletal muscle significantly contributes to the adaptation of the NMJ subsequent to physical activity.


Subject(s)
Muscle, Skeletal/metabolism , Neuromuscular Junction/physiology , Transcription Factors/metabolism , Adaptation, Physiological , Animals , Mice , Mice, Transgenic , Muscle Contraction , Muscle, Skeletal/anatomy & histology , Neuromuscular Junction/anatomy & histology , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Transcription Factors/genetics
3.
J Vis Exp ; (62)2012 Apr 12.
Article in English | MEDLINE | ID: mdl-22525799

ABSTRACT

Human primary muscle cells cultured aneurally in monolayer rarely contract spontaneously because, in the absence of a nerve component, cell differentiation is limited and motor neuron stimulation is missing. These limitations hamper the in vitro study of many neuromuscular diseases in cultured muscle cells. Importantly, the experimental constraints of monolayered, cultured muscle cells can be overcome by functional innervation of myofibers with spinal cord explants in co-cultures. Here, we show the different steps required to achieve an efficient, proper innervation of human primary muscle cells, leading to complete differentiation and fiber contraction according to the method developed by Askanas. To do so, muscle cells are co-cultured with spinal cord explants of rat embryos at ED 13.5, with the dorsal root ganglia still attached to the spinal cord slices. After a few days, the muscle fibers start to contract and eventually become cross-striated through innervation by functional neurites projecting from the spinal cord explants that connecting to the muscle cells. This structure can be maintained for many months, simply by regular exchange of the culture medium. The applications of this invaluable tool are numerous, as it represents a functional model for multidisciplinary analyses of human muscle development and innervation. In fact, a complete de novo neuromuscular junction installation occurs in a culture dish, allowing an easy measurement of many parameters at each step, in a fundamental and physiological context. Just to cite a few examples, genomic and/or proteomic studies can be performed directly on the co-cultures. Furthermore, pre- and post-synaptic effects can be specifically and separately assessed at the neuromuscular junction, because both components come from different species, rat and human, respectively. The nerve-muscle co-culture can also be performed with human muscle cells isolated from patients suffering from muscle or neuromuscular diseases, and thus can be used as a screening tool for candidate drugs. Finally, no special equipment but a regular BSL2 facility is needed to reproduce a functional motor unit in a culture dish. This method thus is valuable for both the muscle as well as the neuromuscular research communities for physiological and mechanistic studies of neuromuscular function, in a normal and disease context.


Subject(s)
Coculture Techniques/methods , Muscles/cytology , Muscles/innervation , Neuromuscular Junction , Spinal Cord/cytology , Animals , Embryo, Mammalian , Female , Humans , Pregnancy , Rats
4.
Gerontology ; 57(1): 37-43, 2011.
Article in English | MEDLINE | ID: mdl-20134150

ABSTRACT

Aging is associated with far-reaching changes in physiological functions resulting in morbidity and ultimately death. Age-related frailty, insecurity and reduced physical activity contribute to a progressive loss of muscle mass and function, commonly referred to as sarcopenia. Due to the increase in life expectancy in many countries, loss of muscle mass and its consequences gain in relevance for public health. At the same time, the molecular mechanisms that underlie sarcopenia are poorly understood and therefore, therapeutic approaches are limited. Interestingly though, endurance, strength and stretching exercise is significantly superior to all known pharmacological, nutritional and hormonal interventions for stabilizing, alleviating and reversing sarcopenia. Thus, increased knowledge about the plastic changes of skeletal muscle after physical activity and the signaling factors that mediate the beneficial effects of exercise on other organs might yield a better understanding of the disease and open new avenues for treatment. Here, we discuss how current discoveries about the peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α), a key exercise factor in muscle, and myokines, factors produced and secreted by active muscle fibers, expand our view of the pathological changes and the therapeutic options for sarcopenia.


Subject(s)
Aging/physiology , Heat-Shock Proteins/physiology , Muscle Proteins/physiology , Muscle, Skeletal/physiology , Transcription Factors/physiology , Aged , Exercise Therapy , Humans , Models, Biological , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Sarcopenia/etiology , Sarcopenia/physiopathology , Sarcopenia/therapy
5.
PLoS One ; 5(6): e10970, 2010 Jun 04.
Article in English | MEDLINE | ID: mdl-20532042

ABSTRACT

Adequate levels of physical activity are at the center of a healthy lifestyle. However, the molecular mechanisms that mediate the beneficial effects of exercise remain enigmatic. This gap in knowledge is caused by the lack of an amenable experimental model system. Therefore, we optimized electric pulse stimulation of muscle cells to closely recapitulate the plastic changes in gene expression observed in a trained skeletal muscle. The exact experimental conditions were established using the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) as a marker for an endurance-trained muscle fiber. We subsequently compared the changes in the relative expression of metabolic and myofibrillar genes in the muscle cell system with those observed in mouse muscle in vivo following either an acute or repeated bouts of treadmill exercise. Importantly, in electrically stimulated C2C12 mouse muscle cells, the qualitative transcriptional adaptations were almost identical to those in trained muscle, but differ from the acute effects of exercise on muscle gene expression. In addition, significant alterations in the expression of myofibrillar proteins indicate that this stimulation could be used to modulate the fiber-type of muscle cells in culture. Our data thus describe an experimental cell culture model for the study of at least some of the transcriptional aspects of skeletal muscle adaptation to physical activity. This system will be useful for the study of the molecular mechanisms that regulate exercise adaptation in muscle.


Subject(s)
Electric Stimulation , Gene Expression Regulation , Muscle, Skeletal/physiology , Physical Conditioning, Animal , Animals , Cell Line , Mice , Muscle, Skeletal/cytology , Muscle, Skeletal/metabolism , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Trans-Activators/metabolism , Transcription Factors , Transcription, Genetic
6.
Dev Dyn ; 237(12): 3577-90, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18697221

ABSTRACT

Flectin, a protein previously described to be expressed in a left-dominant manner in the embryonic chick heart during looping, is a member of the nonmuscle myosin II (NMHC-II) protein class. During looping, both NMHC-IIA and NMHC-IIB are expressed in the mouse heart on embryonic day 9.5. The patterns of localization of NMHC-IIB, rather than NMHC-IIA in the mouse looping heart and in neural crest cells, are equivalent to what we reported previously for flectin. Expression of full-length human NMHC-IIA and -IIB in 10 T1/2 cells demonstrated that flectin antibody recognizes both isoforms. Electron microscopy revealed that flectin antibody localizes in short cardiomyocyte cell processes extending from the basal layer of the cardiomyocytes into the cardiac jelly. Flectin antibody also recognizes stress fibrils in the cardiac jelly in the mouse and chick heart; while NMHC-IIB antibody does not. Abnormally looping hearts of the Nodal(Delta 600) homozygous mouse embryos show decreased NMHC-IIB expression on both the mRNA and protein levels. These results document the characterization of flectin and extend the importance of NMHC-II and the cytoskeletal actomyosin complex to the mammalian heart and cardiac looping.


Subject(s)
Heart/embryology , Myocardium/metabolism , Nonmuscle Myosin Type IIA/metabolism , Nonmuscle Myosin Type IIB/metabolism , Animals , Cell Line , Chick Embryo , Extracellular Matrix Proteins/metabolism , Gene Expression Regulation, Developmental , Genes, Reporter/genetics , Humans , Mice , Mice, Knockout , Nodal Protein/genetics , Nodal Protein/metabolism , Nonmuscle Myosin Type IIA/genetics , Nonmuscle Myosin Type IIB/deficiency , Nonmuscle Myosin Type IIB/genetics , Protein Binding , Proteomics , RNA, Messenger/genetics , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
8.
J Hypertens ; 25(1): 197-205, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17143192

ABSTRACT

OBJECTIVES: Beta-blockers are widely used and effective for treating hypertension, acute myocardial infarction (MI) and heart failure, but they present side-effects mainly due to antagonism of beta2-adrenergic receptor (AR). Currently available beta-blockers are at best selective but not specific for beta1 or beta2-AR. METHODS: To specifically inhibit the expression of the beta1-AR, we developed a small interfering RNA (siRNA) targeted to beta1-AR. Three different sequences of beta1 siRNA were delivered into C6-2B cells with 90% efficiency. RESULTS: One of the three sequences reduced the level of beta1-AR mRNA by 70%. The siRNA was highly specific for beta1-AR inhibition with no overlap with beta2-AR. To test this in vivo, systemic injection of beta1 siRNA complexed with liposomes resulted in efficient delivery into the heart, lung, kidney and liver, and effectively reduced beta1-AR expression in the heart without altering beta2-AR. beta1 siRNA significantly lowered blood pressure of spontaneously hypertensive rats (SHR) for at least 12 days and reduced cardiac hypertrophy following a single injection. Pretreatment with beta1 siRNA 3 days before induction of MI in Wistar rats significantly improved cardiac function, as demonstrated by dP/dt and electrocardiogram following the MI. The protective mechanism involved reduction of cardiomyocyte apoptosis in the beta1 siRNA-treated hearts. CONCLUSIONS: The present study demonstrates the possibility of using siRNA for treating cardiovascular diseases and may represent a novel beta-blocker specific for beta1-AR.


Subject(s)
Antihypertensive Agents/metabolism , Blood Pressure , Hypertension/metabolism , Myocardial Ischemia/metabolism , RNA Interference , RNA, Small Interfering/metabolism , Receptors, Adrenergic, beta-1/metabolism , Animals , Antihypertensive Agents/therapeutic use , Apoptosis , Cell Line, Tumor , Disease Models, Animal , Heart Ventricles/pathology , Hypertension/genetics , Hypertension/pathology , Hypertension/physiopathology , Male , Mice , Myocardial Ischemia/genetics , Myocardial Ischemia/pathology , Myocardial Ischemia/physiopathology , Myocardium/metabolism , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/therapeutic use , Rats , Rats, Inbred SHR , Rats, Wistar , Receptors, Adrenergic, beta-1/genetics , Time Factors , Transfection , Ventricular Function, Left
9.
Fundam Clin Pharmacol ; 20(1): 81-9, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16448398

ABSTRACT

This study compared three different synthetic reagents (FuGENE 6, Effectene and ExGen 500) for the transfection of human primary myoblasts. We examined the efficiency, cytotoxicity and size of the complexes formed in the presence of different amounts of vector and DNA and with variable amounts of serum. Transfection rates were relatively high for primary cells, especially with FuGENE 6 (20%), which appeared to be the best transfection reagent for these cells, even in the presence of 10% serum. Cultured human myoblasts are an interesting tool for studying neuromuscular diseases and are potentially useful for myoblast transfer therapy studies. Moreover, the efficiency of these transfection reagents in a medium containing 10% serum is promising for possible gene therapy protocols for muscle diseases.


Subject(s)
DNA/metabolism , Indicators and Reagents/chemistry , Lipids/chemistry , Myoblasts, Skeletal/metabolism , Polyethyleneimine/chemistry , Polyethyleneimine/toxicity , Transfection , Cell Culture Techniques , Cell Survival , Cells, Cultured , DNA/chemistry , Humans , Lipids/toxicity , Myoblasts, Skeletal/drug effects , Particle Size , Transfection/methods
10.
FEBS Lett ; 580(2): 553-60, 2006 Jan 23.
Article in English | MEDLINE | ID: mdl-16412430

ABSTRACT

Fas/FasL interactions have been proposed as a potentially important mechanism mediating beta-cell death in type 1 diabetes. Recent investigations suggest RNA interference, afforded by small interfering RNAs (siRNA), can provide specific and robust gene silencing in mammalian cells. The current study attempted to investigate the effects of silencing Fas expression with siRNA on Fas-mediated apoptosis in mouse insulinoma cells following cytokine incubation. Our results indicate that siRNA is capable of rapid inhibition of cytokine-induced Fas mRNA production and cell surface Fas protein. A complete suppression of the total Fas protein was only observed after prolonged incubation with siRNA, suggesting a slow turn-over of Fas protein. Moreover, siRNA significantly inhibited Fas-mediated beta-cell apoptosis assessed by Caspase-3 and terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling assays, the extent of which positively correlated with the level of cell surface Fas. These observations provide additional evidence supporting a role for the Fas-mediated pathway in beta-cell destruction, and suggest that siRNA targeting Fas may be of therapeutic value in preventing type 1 diabetes and improving islet cell viability in transplantation.


Subject(s)
Apoptosis/physiology , Cytokines/metabolism , Insulinoma/metabolism , RNA, Small Interfering/metabolism , fas Receptor/metabolism , Animals , Caspase 3 , Caspases/metabolism , Cell Line, Tumor , Gene Silencing , Humans , In Situ Nick-End Labeling , Insulin-Secreting Cells/immunology , Insulin-Secreting Cells/physiology , Mice , fas Receptor/genetics
11.
Lab Invest ; 84(10): 1271-8, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15322565

ABSTRACT

Spinal muscular atrophy (SMA) is an autosomal recessive disorder characterized by degeneration of motoneurons and skeletal muscle atrophy. In its most severe form, it leads to death before the age of 2 years. While primary degeneration of motor neurons is well established in this disease, and this results in neurogenic atrophy of skeletal muscle, we have previously reported evidence for a primary muscle defect. In this study, we used primary cultures of embryonic human skeletal muscle cells from patients with SMA and from controls to examine the effects of muscle fiber differentiation in the absence of a nerve component. Cultured SMA skeletal muscle cells are unable to fuse correctly to form multinuclear myotubes, the precursors of the myofibers. We also show that agrin-induced aggregates of nicotinic acetylcholine receptors, one of the earliest steps of neuromuscular junction formation, cannot be visualized by confocal microscopy on cells from SMA patients. In binding experiments, we demonstrate that this lack of clustering is due to defective expression of the nicotinic acetylcholine receptors in the myotubes of SMA patients whereas the affinity of alpha-bungarotoxin for its receptor remains unchanged regardless of muscle cell type (SMA or control). These observations suggest that muscle cells from SMA patients have intrinsic abnormalities that may affect proper formation of the neuromuscular junction.


Subject(s)
Muscle Fibers, Skeletal/metabolism , Muscle, Skeletal/metabolism , Receptors, Nicotinic/metabolism , Spinal Muscular Atrophies of Childhood/metabolism , Agrin/pharmacology , Bungarotoxins/pharmacology , Cells, Cultured , Fluorescent Antibody Technique, Indirect , Humans , Microscopy, Confocal , Muscle Fibers, Skeletal/drug effects , Muscle Fibers, Skeletal/pathology , Muscle, Skeletal/drug effects , Muscle, Skeletal/pathology , Receptors, Nicotinic/drug effects , Spinal Muscular Atrophies of Childhood/pathology , alpha7 Nicotinic Acetylcholine Receptor
12.
Plasmid ; 47(2): 79-87, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11982329

ABSTRACT

We describe here the construction of plasmid pEGFP-C3/SMN, bearing the human SMN gene coupled to the green fluorescent protein (GFP) sequence. The mutation of the SMN gene is responsible for spinal muscular atrophy (SMA), a frequent human infantile genetic disease. We introduced the SMN cDNA into the multiple cloning site of pEGFP-C3. This plasmid bears the neomycin-resistance sequence and the enhanced green fluorescent protein (EGFP). It results in the expression of a fusion protein bearing SMN coupled to a carboxy-terminal GFP tag, used for fluorescence localization studies. Transfection of primary human myoblasts with pEGFP-C3 or pEGFP-C3/SMN revealed that EGFP is intracellularly localized within the cytosol as well as in the nucleus, while the fusion protein EGFP-SMN localized within the nucleus in prominent dot-like structures termed "gems." These data demonstrate that human primary muscle cells can be efficiently transfected and may have important implications for the development of therapeutic strategies in SMA.


Subject(s)
Luminescent Proteins/genetics , Nerve Tissue Proteins/genetics , Plasmids/genetics , Amino Acid Sequence , Anti-Bacterial Agents/pharmacology , Base Sequence , Cell Nucleus/metabolism , Cells, Cultured , Cyclic AMP Response Element-Binding Protein , Drug Resistance, Microbial/genetics , Green Fluorescent Proteins , Humans , Luminescent Proteins/metabolism , Microscopy, Confocal , Molecular Sequence Data , Muscle, Skeletal/cytology , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Mutation , Neomycin/pharmacology , Nerve Tissue Proteins/drug effects , Nerve Tissue Proteins/metabolism , RNA-Binding Proteins , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , SMN Complex Proteins , Sequence Analysis, DNA , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...